Short-term estrogen test for cytodiagnosis in postmenopausal women
β Scribed by Masamichi Kashimura; Shinji Baba; Shuji Nakamura; Keita Matsukuma; Toshiharu Kamura
- Publisher
- John Wiley and Sons
- Year
- 1987
- Tongue
- English
- Weight
- 420 KB
- Volume
- 3
- Category
- Article
- ISSN
- 8755-1039
No coin nor oath required. For personal study only.
β¦ Synopsis
A short-term estrogen test was used to obtain a correct cytologic diagnosis in 73 patients with an equivocal atrophic cellular pattern. Overestimation in cytodiagnosis was markedly eliminated. and the correct cytologic diagnosis was made in 81 % of the cell samples after the estrogen test. The purpose of this study was not only to confirm the usefulness of the short-term estrogen test, but also to observe the cytomorphologic changes before and after ihe test. Thick cytoplasm, vacuoles in the cytoplasm, and a distinct cell border increased, while the amorphous chromatin pattern was eliminated after the estrogen test. Maturation of atypical cells in cases of dysplasia, carcinoma in situ, and invasive squamous-cell carcinoma was investigated before and afrer the estrogen test. Although malignant cells were not injluenced by estrogen, maturation of dysplastic cells was induced after the test. Diagn Cytopathol
1987;3: 181-1 84.
π SIMILAR VOLUMES
Whereas the structural implications of drug intervention are well established, there are few data on the possible mechanical consequences of treatment. In this work we examined the changes in elastic and shear moduli (EM and SM) in a region of trabecular bone in the distal radius and distal tibia of
Tamoxifen has proven to be beneficial in the chemoprevention of breast cancer in women at increased risk for the disease. Other compounds that mediate the estrogen pathway remain to be tested for clinical efficacy. The mechanism of action, efficacy, and dose response of the estrogen modulators is de
Recently, a membrane-based estrogen receptor (ER), ER-Ξ±36, was identified and cloned that transduces membrane-initiated estrogen signaling such as activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK) signaling pathway. Here we show that the postmenopaus